Kalbe Farma Tbk vs Suparma Tbk. — how do they compare? Kalbe Farma Tbk trades at Rp720 (market cap 33T, 98.44M 24h volume), while Suparma Tbk. trades at Rp168 (market cap 688.85B, 577.4K 24h volume). The key difference: Kalbe Farma Tbk is far larger — about 47.9× Suparma Tbk.'s market cap, and Kalbe Farma Tbk is more actively traded (98.44M versus 577.4K). Which is the better fit depends on your goals.
| KLBF | SPMA | |
|---|---|---|
Market Cap | 33T | 688.85B |
Volume | 98.44M | 577.4K |
Lot | 984.38K | 5.77K |
Turnover | 70.64B | 96.55M |
Average Price | 717.58 | 167.22 |
Value | 70.64B | 96.55M |
Indicative Equilibrium Price | 720 | 168 |
Indicative Equilibrium Volume | 43.62K | 37 |
Trailing returns across standard periods
Latest headlines on both assets
PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Read more on KLBF →PT Suparma Tbk (Entity) was established under the Domestic Capital Investment Law No. 6 of 1968 as amended by Law No. 12 of 1970 based on the Notarial Deed No. 29 of Tjahjadi Hartanto, S.H., on August 25, 1976. The Entity's name, PT Supar Inpama was changed to PT Suparma based in the Notarial Deed No. 5 dated December 7, 1978 of the same notary.
Read more on SPMA →